Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Antioxidants and mineral supplements for slowing age-related macular degeneration
Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...
How AI might help identify adverse drug events
The development of natural language processing (NLP) capabilities is opening new avenues for pharmacovigilance and pharmacists can play a key role in the process.
US...
PSA successfully lobbies for pharmacist recommendations
Pharmacists have been recommended to access Medicare Benefits Schedule (MBS) items to manage medicines for patients who require complex care.
The Pharmaceutical Society of Australia...
Parents susceptible to anti-vaccine messages from public figures
A new study has found that parents who generally accept vaccination are susceptible to anti-vaccination rhetoric from politicians, suggesting that vaccine messaging needs to...
PSA: pharmacists need support to improve Australia’s health
Following the announcement of this year’s Federal Election date, PSA looks forward to working with an incoming Government to support a healthier Australia by...
We must embrace change and lead new models of care
Since becoming National President, I have received significant levels of feedback in support of PSA’s development of pharmacists working in general practice.
I have also...
